Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin ® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label

Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin ® (methocarbamol tablets, USP) 750mg Tablets 100 Count Bottle pack to the consumer level. The products have been found to have incorrect daily dosing information on the label due to a labeling error which misstates the daily dose as " two to four tablets four times daily " rather than the correct dosage of " two tablets three times daily. " (see picture below for location of incorrect text).
Source: Food and Drug Administration - Category: Food Science Source Type: news